col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt

Verlag: Societatea de Stiinte Farmaceutice din Romania

37 Ergebisse       Seite 1

 [1] 
  Original Artikel Journal Datum Titel Autoren Alle Autoren
1 [GO] FARMACIA 2026―Okt―22 RISK STRATIFICATION OF COVID-19 SEVERITY IN CANCER PATIENTS USING MACHINE LEARNING ALGORITHMS ELENA-VICTORIA MANEA (CARNELUTI), STEFAN-ALEXANDRU ARTENE, ANDREEA DENISA HODOROG, MIRCEA-SEBASTIAN SERBANESCU, IRINA ANNA-MARIA STOIAN, ILONA GEORGESCU, et al. (+3)
2 [GO] FARMACIA 2026―Okt―22 PHARMACEUTICAL ETHICS IN CRISIS: LESSONS LEARNED FROM THE COVID-19 PANDEMIC AND RECOMMENDATIONS FOR FUTURE PREPAREDNESS IN ROMANIA AND SIMILAR HEALTHCARE SYSTEMS LUCIA MARIA RUS, SIMONA CODRUȚA HEGHEȘ, ADELA CACOVEAN, LIGIA-ANCUȚA HUI, ALINA UIFĂLEAN, CRISTINA ADELA IUGA, HORAȚIU COLOSI
3 [GO] FARMACIA 2026―Okt―22 INFLAMMATORY RATIO BIOMARKERS FOR PROGNOSTIC AND THERAPEUTIC GUIDANCE IN CRITICAL COVID-19 CARE DEJANA D. BAJIĆ, NEMANJA B. TODOROVIĆ, MLADENA N. LALIĆ POPOVIĆ, LJILJANA N. ANDRIJEVIĆ
4 [GO] FARMACIA 2025―Jul―24 THE ROLE OF IL-6 AND IL-1 IN COVID-19 DISEASE PROGRESSION: THE IMPACT OF GENDER-BASED DIFFERENCES, BMI VARIABILITY AND CO-MEDICATIONS Aida-Isabela Adamescu
5 [GO] FARMACIA 2023―Nov―20 ANTIVIRAL ACTIVITY OF ORIGINAL FLAVONOIDS-CONTAINING PHYTOPREPARATION AGAINST HUMAN ALPHAHERPESVIRUS 2, HEPATITIS C SURROGATE VIRUS AND TRANSMISSIBLE GASTROENTERITIS CORONAVIRUS ALEXANDER GALKIN 
6 [GO] FARMACIA 2023―Jul―20 THE EFFICACY OF ANTIDEPRESIVE TREATMENT ON COVID-19 PANDEMIC-RELATED DEPRESSIVE SYMPTOMS - A PROSPECTIVE, SINGLE-CENTER, QUESTIONNAIRE-BASED STUDY ANDREEA SĂLCUDEAN 
7 [GO] FARMACIA 2023―Jul―20 PERCEPTIONS OF FRONTLINE HEALTHCARE PROFESSIONALS ON COVID-19 VACCINATION RALUCA ELISABETA LUPAȘCU MOISI
8 [GO] FARMACIA 2023―Mrz―16 THE EVOLUTION AND TREATMENT OPTIONS OF PATIENTS WITH COVID-19 AND NEUROLOGICAL MANIFESTATIONS - A NARRATIVE REVIEW IRINA ODAJIU
9 [GO] FARMACIA 2023―Mrz―16 EVALUATION OF KNOWLEDGE ON THE PREVENTIVE PRACTICE OF COVID-19 AMONG MIDDLE-AGED ADULTS IN SAUDI ARABIA - A CROSS-SECTIONAL QUESTIONNAIRE BASED STUDY MAHMOOD BASIL A. AL-RAWI
10 [GO] FARMACIA 2023―Mrz―16 STUDY ON THE INCIDENCE AND PROFILE OF RISK FACTORS IN THE FIELD OF HEALTHCARE PRACTICE IN PHARMACEUTICAL CARE DURING THE COVID-19 PANDEMIC PERIOD CLAUDIA-CAMELIA BURCEA 
11 [GO] FARMACIA 2023―Mrz―16 THE COVID-19 PANDEMIC′S IMPACT ON HEALTHCARE PROFESSIONALS′ MENTAL HEALTH MATEI PALIMARICIUC
12 [GO] FARMACIA 2023―Mrz―16 THE IMPACT OF INFLAMMATION AND DRUG INTERACTIONS ON COVID-19 PHARMACOTHERAPY. A MINI-REVIEW MONICA NEAMȚU
13 [GO] FARMACIA 2022―Jul―14 THE EVALUATION OF VITAMIN D DEFICIENCY AS A RISK FACTOR IN THE CASE OF PATIENTS WITH MODERATE COVID-19 LAURA-CORINA NICOLESCU
14 [GO] FARMACIA 2022―Jul―14 CHALLENGES REGARDING THE INTERACTION BETWEEN PSYCHOTROPICS AND COVID-19 CO-MEDICATION CĂTĂLINA-ANGELA CRIȘAN
15 [GO] FARMACIA 2022―Jul―14 ARTEMISIA SPECIES AND ARTEMISININ DERIVATIVES AS ANTIVIRAL AGENTS AGAINST COVID-19. CURRENT KNOWLEDGE: CHEMISTRY, PHARMACOLOGY AND CLINICAL EVIDENCE MOHAMMAD HUDAIB
16 [GO] FARMACIA 2022―Jul―14 LATE-ONSET EPILEPSY IN THE ELDERLY: DIFFICULTIES OF DIAGNOSIS AND PERSONALIZED PHARMACOLOGICAL MANAGEMENT, WITH PARTICULARITIES TO COVID-19 PANDEMIC - SYSTEMATIC REVIEW OF LITERATURE AURELIAN ANGHELESCU
17 [GO] FARMACIA 2022―Jul―14 KNOWLEDGE AND ATTITUDE OF PHARMACY STUDENTS TOWARDS COVID-19 PANDEMIC AND ITS IMPACT ON THEIR EDUCATION AND LEARNING BASIT L. JAN
18 [GO] FARMACIA 2022―Mrz―10 EARLY USE OF REMDESIVIR IN OBESE MALE PATIENTS WITH COVID-19 CAN IMPROVE THE PROGNOSIS CRISTINA POPESCU
19 [GO] FARMACIA 2022―Mrz―10 SATISFACTION WITH THE PROFESSION OF PHARMACISTS, ESPECIALLY DURING THE 2019 CORONAVIRUS PANDEMIC WERONIKA GUZENDA
20 [GO] FARMACIA 2022―Mrz―10 REAL-LIFE COMPARISON OF TOCILIZUMAB AND ANAKINRA ASSOCIATED WITH CORTICOSTEROID USE IN A COHORT OF HOSPITALIZED PATIENTS WITH SARS-CoV-2 INFECTION LAURENȚIU MIHĂIȚĂ STRATAN
21 [GO] FARMACIA 2022―Feb―02 OXIDATIVE STRESS AND CYTOKINES’ INVOLVEMENT IN THE OCCURENCE AND PROGRESSION OF DIABETIC COMPLICATIONS IN THE COVID-19 PANDEMIC CONTEXT MARIANA CORNELIA TILINCA
22 [GO] FARMACIA 2022―Feb―02 THE ROLE OF HMGB1 IN THE IMMUNE RESPONSE TO SARS-COV-2 INFECTION: FROM PATHOGENESIS TOWARDS A NEW POTENTIAL THERAPEUTIC TARGET MUHAMMAD TOREQUL ISLAM
23 [GO] FARMACIA 2022―Jan―20 POSSIBLE MUTATION PATHWAYS IN SARS-CoV-2 MUHAMMAD TOREQUL ISLAM
24 [GO] FARMACIA 2021―Mai―06 KEY POINTS IN FERTILITY PRESERVATION TREATMENT STRATEGIES DURING COVID-19 PANDEMIC. AN UPDATE ON PHARMACOLOGICAL THERAPIES VALENTIN NICOLAE VARLAS
25 [GO] FARMACIA 2021―Mrz―01 THE IMPACT OF COVID-19 LOCKDOWN ON THE LIFESTYLE AND DIETARY PATTERNS AMONG ROMANIAN POPULATION MAGDALENA MITITELU
26 [GO] FARMACIA 2021―Jan―14 HIGH SKIN MELANIN CONTENT, VITAMIN D DEFICIENCY AND IMMUNITY: POTENTIAL INTERFERENCE FOR SEVERITY OF COVID-19 MUHAMMAD TOREQUL ISLAM
27 [GO] FARMACIA 2021―Jan―14 NITRIC OXIDE PATHWAY AS A POTENTIAL THERAPEUTIC TARGET IN COVID-19 KHALID M. ALKHARFY
28 [GO] FARMACIA 2021―Jan―14 STUDY OF AVAILABLE ANTIVIRAL TREATMENTS FOR COVID-19 DURING PREGNANCY OCTAVIAN GABRIEL OLARU
29 [GO] FARMACIA 2020―Nov―05 LYSOSOMOTROPIC PROPERTIES OF SODIUM BICARBONATE AND COVID-19 MUDASIR MIR
30 [GO] FARMACIA 2020―Nov―05 INFLUENCE OF TOCILIZUMAB ON THE OUTCOME OF PATIENTS WITH COVID-19. RETROSPECTIVE OBSERVATIONAL STUDY EUGENIA IRENE DAVIDESCU
31 [GO] FARMACIA 2020―Nov―05 NON-ALCOHOLIC FATTY LIVER DISEASE IN DIABETIC PATIENTS AS RISK FACTOR FOR POOR PROGNOSIS OF COVID-19: AN UPDATE OF POTENTIAL MECHANISMS AND TREATMENT CONSIDERATIONS OVIDIU PAUL CALAPOD
32 [GO] FARMACIA 2020―Aug―03 A FOLLOW-UP STUDY OF THE OCCUPATIONAL HAND ECZEMA AND SKIN DAMAGE RISK IN HEALTHCARE PROVIDERS FROM ROMANIA IN TIME OF COVID-19 ANCA E. CHIRIAC
33 [GO] FARMACIA 2020―Aug―03 TREATMENT WITH HYDROXYCHLOROQUINE IN PATIENTS WITH COVID-19. EXPERIENCE OF A NEUROLOGY DEPARTMENT EUGENIA IRENE DAVIDESCU
34 [GO] FARMACIA 2020―Aug―03 ASSERTION FOR MONTELUKAST IN THE COVID-19 PANDEMICS? ANDRA IULIA SUCEVEANU
35 [GO] FARMACIA 2020―Jun―29 HYDROXYCHLOROQUINE AND AZITHROMYCIN COMBINATION COULD BE LETHAL TO COVID-19 PATIENTS FIRDOUS SAYEED MOHAMMAD
36 [GO] FARMACIA 2020―Jun―29 DIABETES AND RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM: IMPLICATIONS FOR COVID-19 PATIENTS WITH DIABETES TREATMENT MANAGEMENT DOINA CATRINOIU
37 [GO] FARMACIA 2020―Apr―29 A NEW ERA FOR THE THERAPEUTIC MANAGEMENT OF THE ONGOING COVID-19 PANDEMIC ANDREEA LETIȚIA ARSENE
 [1] 

37 Ergebisse       Seite 1




[de][en]

Letzte Änderung 2026―Nov―15 17:31:27 UTC

© Daten-Quadrat 2022       Done in 0.005 sec